Stay updated on AKST4290 with Aflibercept in nAMD Clinical Trial
Sign up to get notified when there's something new on the AKST4290 with Aflibercept in nAMD Clinical Trial page.

Latest updates to the AKST4290 with Aflibercept in nAMD Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe study history now includes a new revision entry (v3.6.6), updating the version history to reflect the latest platform release.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe study record history shows a new revision entry (v3.6.5) and removes the previous revision (v3.6.4) from the visible list, reflecting an updated versioning state.SummaryDifference0.1%

- Check43 days agoChange DetectedThe study record history now shows a new latest revision (v3.6.4) replacing the previous v3.6.3 in the version list.SummaryDifference0.1%

- Check64 days agoChange DetectedA new version tag (v3.6.3) appears in the study history, replacing the previous v3.6.2. This signifies an administrative update or quality-control revision to the record rather than changes to study data.SummaryDifference0.1%

- Check72 days agoChange DetectedA new revision entry (v3.6.2) was added to the study's record history, and the older revision (v3.6.0) was removed from the list. This updates the visible history of the page without changing substantive study information.SummaryDifference0.1%

- Check86 days agoChange DetectedA new note in the history indicates recruitment has ended with 'No longer looking for participants,' and the history adds a new version (v3.6.0) while removing the previous version (v3.5.5).SummaryDifference0.4%

Stay in the know with updates to AKST4290 with Aflibercept in nAMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AKST4290 with Aflibercept in nAMD Clinical Trial page.